Xtane Tablet (Exemestane) – Post-Menopausal Breast Cancer Aromatase Inhibitor

Xtane (Exemestane) is a prescription targeted oncology medication for the treatment of hormone receptor-positive breast cancer in post-menopausal women. As a targeted therapy, it works at a molecular level to slow cancer cell proliferation while sparing healthy tissue.
Composition: Exemestane (25mg)
Manufacturer: Natco Pharma Ltd
Prescription-only oncology medication. Use only under the direct supervision of a licensed oncologist. Regular blood tests and monitoring are mandatory throughout treatment.